Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
ACS Chemical Neuroscience|August 4, 2012
Fragile X syndrome: an update on developing treatment modalitiesAileen Healy, Roger Rush, Timothy OcainMetabolites|June 25, 2014
Metabolic and Pharmacokinetic Differentiation of STX209 and Racemic Baclofen in HumansRaymundo Sanchez-Ponce, Li-Quan Wang, Wei Lu, et al.Biological & Pharmaceutical Bulletin|March 12, 2015
Overcoming stability challenges in the quantification of tissue nucleotides: determination of 2'-C-methylguanosine triphosphate concentration in mouse liverHassan Rashidzadeh, Sanjeev Bhadresa, Steven Spencer Good, et al.Journal of Medicinal Chemistry|May 13, 2014
Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines as α7 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disordersRoger B Clark, Diana Lamppu, Lyn Libertine, et al.European Journal of Drug Metabolism and Pharmacokinetics|April 23, 2015
Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposureXin-Ru Pan-Zhou, Benjamin A Mayes, Hassan Rashidzadeh, et al.Science Translational Medicine|September 21, 2012
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofenChristina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, et al.Science Translational Medicine|January 18, 2023
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's diseaseSenthilkumar S Karuppagounder, Hu Wang, Terence Kelly, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2012
The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5Ryan D Morrison, Anna L Blobaum, Frank W Byers, et al.Pageof 1